Clinical efficacy of tezepelumab in pre‐selected non‐type 2 asthma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical efficacy of tezepelumab in pre‐selected non‐type 2 asthma patients

Published:2024-07-22 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Chin‐See‐Chong T. C. (Timothy)¹,Valk J. P. M. (Johanna) van der¹²,Layhadi J. A. (Janice)³⁴,Shamji M. H. (Mohamed)³⁴^ORCID,Kappen J. H. (Jasper)¹³⁴^ORCID

Affiliation:

1. Department of Pulmonary Diseases Franciscus Gasthuis & Vlietland Rotterdam The Netherlands

2. Department of Pulmonary Diseases Erasmus Medical Centrum Rotterdam The Netherlands

3. National Heart and Lung Institute Imperial College London London UK

4. Asthma UK Centre in Allergic Mechanisms of Asthma London UK

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.16237

Reference6 articles.

1. Thymic stromal lymphopoietin (TSLP), its isoforms and the interplay with the epithelium in allergy and asthma;Smolinska S;Int J Mol Sci,2023

2. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

3. Tezepelumab in Adults with Uncontrolled Asthma

4. https://ginasthma.org/2023‐gina‐main‐report/

5. The efficacy and safety of tezepelumab in the treatment of uncontrolled asthma: a systematic review and meta‐analysis of randomized controlled trials;Lin F;Medicine (Baltimore),2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP